Chunk #29 — TREATMENT OF CANNABIS DEPENDENCE — 3.3. Other Approaches — 3.3.d. Norepinephrine Reuptake Inhibitor- Atomoxetine
Text
A more recent double-blind, placebo-controlled 12-week study of atomoxetine (25–100 mg/day escalating doses) in 38 cannabis-dependent outpatients with concurrent ADHD found no significant change in cannabis use, although there was some improvement in ADHD symptoms [74].